Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Compound Norethisterone Enanthate Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Contraception Behavior
1 trial -
Contrast-enhanced ultrasound-guided core biopsy
The First People's Hospital of Lianyungang
Pancreatic Disease
1 trial -
Conventional Artificial Cycle Therapy
Jian Li
Infertility, Female
1 trial -
Conventional second-line therapy
The First People's Hospital of Lianyungang
Colorectal Cancer (CRC)
1 trial -
Conventional third-line therapy
The First People's Hospital of Lianyungang
Colorectal Cancer (CRC)
1 trial -
Conventional treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Copd Exacerbation Acute
1 trial -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Statin
1 trial -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Primary Prevention Strategy
1 trial -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Major Adverse Cardiovascular Events (MACE)
1 trial -
Cow's milk
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Respiratory Infection
1 trial -
Cy-TB test
International Peace Maternity and Child Health Hospital
Latent Tuberculosis
1 trial -
DAOSiN®/ Placebo & ProvokAmin® Ingestion
Century Therapeutics
Histamine Intolerance
1 trial -
DGB-01 Supplementation
Blackmores Limited
Fatigue
1 trial -
Dairy based toddler nutrition
United Therapeutics Europe Ltd
Weight Gain
1 trial -
Dapagliflozin Treatment Group
The First People's Hospital of Lianyungang
Atrial Fibrillation (AF)
1 trial -
Daratumumab
The First People's Hospital of Lianyungang
Antibody-mediated Rejection
1 trial -
Depot Naltrexone
BRIGHT MINDS BIOSCIENCES INC.
Opioid Dependence
1 trial -
Device measurements
COGNITION THERAPEUTICS INC
Healthy
1 trial -
Device measurements during overnight sleep and morning wake
COGNITION THERAPEUTICS INC
Healthy
1 trial -
Dexmedetomidine Injection
The First People's Hospital of Lianyungang
Coronary Disease
1 trial -
Dexmedetomidine Injection (nasal spray) + Propofol Injection + Sufentanil Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dexmedetomidine Induced Sedation
1 trial -
Dexmedetomidine injection
United Therapeutics Europe Ltd
Delirium in Old Age
1 trial -
Dexmedetomidine ropivacaine
The First People's Hospital of Lianyungang
Pharmacological Action
1 trial -
Dexmedetomidine-Esketamine Combination
The First People's Hospital of Lianyungang
Aged
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources